ArticleIn vivo (Athens, Greece)

Neoadjuvant Chemohormonal Therapy for Patients With Very-high Risk Localized Prostate Cancer in Clinical Stages T2 and T3a.

Daiki Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.